| Reference : Understanding the role of colorectal cancer-associated bacteria in colorectal cancer |
| Dissertations and theses : Doctoral thesis | |||
| Life sciences : Biochemistry, biophysics & molecular biology Life sciences : Genetics & genetic processes Life sciences : Microbiology Engineering, computing & technology : Computer science | |||
| Systems Biomedicine | |||
| http://hdl.handle.net/10993/46919 | |||
| Understanding the role of colorectal cancer-associated bacteria in colorectal cancer | |
| English | |
Ternes, Dominik  [University of Luxembourg > Faculty of Science, Technology and Medicine (FSTM) > Department of Life Sciences and Medicine (DLSM) >] | |
| 19-Apr-2021 | |
| University of Luxembourg, Luxembourg | |
| Doctorate en Biologie | |
| Haan, Serge | |
| Wilmes, Paul | |
| Letellier, Elisabeth | |
| [en] Microbiome ; Colorectal Cancer ; Systems Biology | |
| [en] Mounting evidence from 16S rRNA-based or metagenomic analyses suggests that
dysbiosis, a state of pathological microbial imbalance, is prevalent in the gut of patients with CRC. Numerous microbial taxa have been identified of which representative isolate cultures can interact with cancer cells, further triggering distinct disease pathways in animal models. Nevertheless, how these complex interrelationships of a dysbiotic microbiota may be involved in the pathogenesis of CRC remains a fundamental question and requires multifaceted mechanistic studies. This thesis moves beyond observational studies, it integrates novel experimental approaches for the study of the gut microbiome in colorectal cancer. It incorporates current knowledge in the field as well as interdisciplinary approaches. My work aims at contributing to an ecosystem-level mechanistic understanding of the CRC-associated microbiome in the initiation and progression of the disease. In detail, the objective of my work comprised an integrative approach of microbiome-CRC interaction studies. We revised current knowledge on, and studied the CRC-associated bacteria, in particular Fusobacterium nucleatum (Fn) and Gemella morbillorum (Gm). We assessed their direct and indirect effects on CRC cells, their interactions with immune cells, as well as their tumor-modulating potential in vitro, in silico, and in vivo. The results presented in this thesis comprise new findings on human microbial cross-talk of Fn with CRC. We identified formate as a potential fusobacterial oncometabolite, which enhanced cancer incidence and progression via increased cancer stemness signaling. Furthermore, we discovered immune-suppressive functions of Gm in the context of CRC. With my work in collaboration projects, I contributed to the development of two novel approaches in anti-cancer therapy: First, to the establishment of a personalized in vitro model (iHuMiX) for the study of microbe-host-immune interactions in anti-cancer therapy, and second, to the validation of an in silico workflow that uses metabolic rewiring strategies for network-based drug target predictions for CRC therapy. Taken together, this thesis work broadened the mechanistic understanding of CRC-associated microbes and it contributed to potential strategies for the development of an improved CRC therapy. | |
| Fonds National de la Recherche - FnR ; Internal Research Project grant provided by the University of Luxembourg ; Action LIONS Vaincre le Cancer Luxembourg ; Fondation du Pélican de Mie et Pierre Hippert-Faber, under the aegis of the Fondation de Luxembourg | |
| http://hdl.handle.net/10993/46919 |
| File(s) associated to this reference | ||||||||||||||
|
Fulltext file(s):
| ||||||||||||||
All documents in ORBilu are protected by a user license.
